Clous

FILANA THERAPEUTICS, INC.

Nasdaq: FLNA

Pharmaceutical Preparations · Entity-resolved by Clous

CIK0001069530
TickerFLNA
ExchangeNasdaq
SIC2834
StateDE
FY end12-31

Illustrative profile — live data lights up when a server API key is configured.

Key financials

Revenue
Net IncomeFY2025-12-31
-$90.97M
-273.7% YoY
Total AssetsFY2025-12-31
$118.36M
-24.9% YoY
EquityFY2025-12-31
$74.4M
-48.9% YoY
Shares OutstandingFY2025-12-31
48.31M
Operating Cash FlowFY2025-12-31
-$32.25M
+72.4% YoY

Market

Market
FLNA
Close price
$1.22
Market cap
$58.94M
delayed EOD · as of 2026-06-18
ConceptFY2022-12-31FY2023-12-31FY2024-12-31FY2025-12-31YoY% rev
Net Income-$76.25M-$97.22M-$24.34M-$90.97M-273.7%
Total Assets$234.83M$151.66M$157.53M$118.36M-24.9%
Equity$227.54M$137.47M$145.7M$74.4M-48.9%
Operating Cash Flow-$77.51M-$82.03M-$116.93M-$32.25M+72.4%
Shares Outstanding48.31M
Source: SEC EDGAR · resolved by Clous · as of 2026-05-30Warehouse synced 2026-06-20 06:30 UTC

Get this entity — and 970.89K+ others — programmatically.

One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.

GET /v1/entities?cik=0001069530